Abstracts are eligible to be selected for an oral or a poster presentation
About the Conference:
The ESH 3rd TRANSLATIONAL RESEARCH CONFERENCE: IMMUNE & CELLULAR THERAPIES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune & cellular therapies with a focus on advanced gene-engineered immune cells.
New data will be presented and spirited debates on how to best to apply these insights to the future of immune & cellular therapies are expected.
CONFERENCE'S MAIN SCIENTIFIC TOPICS
• Clinical development of CAR-T cell therapy
• Emerging targets for cell therapy
• Receptor engineering for tumor therapy
• Gene editing to enhance efficacy
• Novel cell types and sources – beyond autologous
• Engineering immune cells in vivo
• Correlative analyses of response and resistance
• Overcoming barriers to improve response
• The future of engineered cell therapy
CLICK HERE TO READ THE PRELIMINARY PROGRAMME